Gara Jalqabaatti › Infeekshinii Vaayirasii Epstein-Barr
Qorannoo klinikaalii Infeekshinii Vaayirasii Epstein-Barr Ameerikaa Keessatti hirmaatuu
Qorannoo 16 Infeekshinii Vaayirasii Epstein-Barr f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 29 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06908096Donor-Derived Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 1/2
4 Weeks · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 2
2 Days · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02532452A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06789159A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin hundi · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT03394365Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Namoota walitti qabaa jiraSadarkaa 1
3 Months – 26 Years · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT06926894Genetic Studies of Chronic Active Epstein-Barr Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 1 hanga 120 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT00032513EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin hundi · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT04664179Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06682442TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin hundi · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT04013802R-MVST Cells for Treatment of Viral Infections
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05183490Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 65 Years · Saalaa hunda · Haaromfame 14-Hag-2025 · NCT06909110EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Namoota walitti qabaa jiraSadarkaa 2
1 Month – 79 Years · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT03266653Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.